These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18283336)

  • 1. Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells.
    Henkhaus RS; Roy UK; Cavallo-Medved D; Sloane BF; Gerner EW; Ignatenko NA
    Neoplasia; 2008 Feb; 10(2):140-8. PubMed ID: 18283336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.
    Henkhaus RS; Gerner EW; Ignatenko NA
    Biol Chem; 2008 Jun; 389(6):757-64. PubMed ID: 18627290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific microRNA-mRNA Regulatory Network of Colon Cancer Invasion Mediated by Tissue Kallikrein-Related Peptidase 6.
    Sells E; Pandey R; Chen H; Skovan BA; Cui H; Ignatenko NA
    Neoplasia; 2017 May; 19(5):396-411. PubMed ID: 28431272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of human mesenchymal stem cell osteogenesis by PI3-kinase/Akt signaling, and the influence of caveolin-1/cholesterol homeostasis.
    Baker N; Sohn J; Tuan RS
    Stem Cell Res Ther; 2015 Dec; 6():238. PubMed ID: 26626726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.
    Kim JJ; Kim JT; Yoon HR; Kang MA; Kim JH; Lee YH; Kim JW; Lee SJ; Song EY; Myung PK; Lee HG
    Tumour Biol; 2012 Jun; 33(3):731-8. PubMed ID: 22373580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers.
    Yousef GM; Borgoño CA; Popalis C; Yacoub GM; Polymeris ME; Soosaipillai A; Diamandis EP
    Anticancer Res; 2004; 24(1):43-51. PubMed ID: 15015574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kallikrein-related peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma.
    Vakrakou A; Devetzi M; Papachristopoulou G; Malachias A; Scorilas A; Xynopoulos D; Talieri M
    Biol Chem; 2014 Sep; 395(9):1105-17. PubMed ID: 25153391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.
    Bouzid H; Soualmia F; Oikonomopoulou K; Soosaipillai A; Walker F; Louati K; Lo Dico R; Pocard M; El Amri C; Ignatenko NA; Darmoul D
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Let‑7i‑5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikrein‑related peptidase 6.
    Song J; Wang L; Ma Q; Yang Y; Yang Z; Wang B; He N
    Oncol Rep; 2018 Sep; 40(3):1459-1466. PubMed ID: 30015976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
    Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
    Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells.
    Martinez NA; Ayala AM; Martinez M; Martinez-Rivera FJ; Miranda JD; Silva WI
    J Biol Chem; 2016 Jun; 291(23):12208-22. PubMed ID: 27129210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.
    Kim TW; Lee SJ; Kim JT; Kim SJ; Min JK; Bae KH; Jung H; Kim BY; Lim JS; Yang Y; Yoon DY; Choe YK; Lee HG
    Oncotarget; 2016 Dec; 7(51):85332-85348. PubMed ID: 27863404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical pathways mediated by KLK6 protease in breast cancer.
    Pampalakis G; Zingkou E; Sidiropoulos KG; Diamandis EP; Zoumpourlis V; Yousef GM; Sotiropoulou G
    Mol Oncol; 2019 Nov; 13(11):2329-2343. PubMed ID: 30980596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference of PARG could inhibit the metastatic potency of colon carcinoma cells via PI3-kinase/Akt pathway.
    Li Q; Li M; Wang YL; Fauzee NJ; Yang Y; Pan J; Yang L; Lazar A
    Cell Physiol Biochem; 2012; 29(3-4):361-72. PubMed ID: 22508044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase.
    Di Vizio D; Adam RM; Kim J; Kim R; Sotgia F; Williams T; Demichelis F; Solomon KR; Loda M; Rubin MA; Lisanti MP; Freeman MR
    Cell Cycle; 2008 Jul; 7(14):2257-67. PubMed ID: 18635971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src-mediated phosphorylation, ubiquitination and degradation of Caveolin-1 promotes breast cancer cell stemness.
    Yoon HJ; Kim DH; Kim SJ; Jang JH; Surh YJ
    Cancer Lett; 2019 May; 449():8-19. PubMed ID: 30673589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RhoA activation in mesangial cells by mechanical strain depends on caveolae and caveolin-1 interaction.
    Peng F; Wu D; Ingram AJ; Zhang B; Gao B; Krepinsky JC
    J Am Soc Nephrol; 2007 Jan; 18(1):189-98. PubMed ID: 17121865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.
    Ogawa K; Utsunomiya T; Mimori K; Tanaka F; Inoue H; Nagahara H; Murayama S; Mori M
    Clin Cancer Res; 2005 Apr; 11(8):2889-93. PubMed ID: 15837738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer.
    Kim JT; Song EY; Chung KS; Kang MA; Kim JW; Kim SJ; Yeom YI; Kim JH; Kim KH; Lee HG
    Cancer; 2011 Jun; 117(12):2608-19. PubMed ID: 21656738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.
    Sidiropoulos KG; Ding Q; Pampalakis G; White NM; Boulos P; Sotiropoulou G; Yousef GM
    Mol Oncol; 2016 Aug; 10(7):993-1007. PubMed ID: 27093921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.